Randal H Henderson, MD, MBA

Research at a glance

Top areas of exploration

Prostatic Neoplasms , 39 publications
Proton Therapy , 34 publications
Radiotherapy Dosage , 14 publications
Radiotherapy Planning, Computer-Assisted , 10 publications

Research activity

80 publications

1,237 citations

Why is this important?

Active clinical trials

Postoperative or Salvage RT for Node Negative Prostate Cancer Following Radical Prostatectomy

The purpose of this study is to see what effects, good and/or bad, proton radiation, and/or conventional radiation and hormonal therapy (if applicable), has on prostate cancer that has already returned or the risk of prostate cancer returning.

Investigator: Randal H Henderson
Status: Accepting Candidates
Ages: 18 Years - N/A
Sexes: Male

My publications

80 publications

2024

A pooled patient-reported outcomes analysis of moderately hypofractionated proton beam therapy and photon-based intensity modulated radiation therapy for low- or intermediate-risk prostate cancer.

The Prostate

PubMed • Publisher's site

2023

Local salvage of radiorecurrent prostate cancer.

The Prostate

PubMed • Publisher's site

2023

Magnetic resonance imaging radiomic features for recurrent prostate cancer following proton radiation therapy-A pilot study.

Urologic oncology

PubMed • Publisher's site

2023

Proton Therapy With Concurrent Chemotherapy for Thoracic Esophageal Cancer: Toxicity, Disease Control, and Survival Outcomes.

International journal of particle therapy

PubMed • Publisher's site

2022

Five- and seven-year outcomes for image-guided moderately accelerated hypofractionated proton therapy for prostate cancer.

Acta oncologica (Stockholm, Sweden)

PubMed • Publisher's site

My Location

Research at a glance

Top areas of exploration

Research activity

Active clinical trials

My publications

A pooled patient-reported outcomes analysis of moderately hypofractionated proton beam therapy and photon-based intensity modulated radiation therapy for low- or intermediate-risk prostate cancer.

Local salvage of radiorecurrent prostate cancer.

Magnetic resonance imaging radiomic features for recurrent prostate cancer following proton radiation therapy-A pilot study.

Proton Therapy With Concurrent Chemotherapy for Thoracic Esophageal Cancer: Toxicity, Disease Control, and Survival Outcomes.

Five- and seven-year outcomes for image-guided moderately accelerated hypofractionated proton therapy for prostate cancer.

Provide website feedback?

Site Feedback

Research at a glance

Top areas of exploration

Research activity

Active clinical trials

My publications

Filter publications

A pooled patient-reported outcomes analysis of moderately hypofractionated proton beam therapy and photon-based intensity modulated radiation therapy for low- or intermediate-risk prostate cancer.

Local salvage of radiorecurrent prostate cancer.

Magnetic resonance imaging radiomic features for recurrent prostate cancer following proton radiation therapy-A pilot study.

Proton Therapy With Concurrent Chemotherapy for Thoracic Esophageal Cancer: Toxicity, Disease Control, and Survival Outcomes.

Five- and seven-year outcomes for image-guided moderately accelerated hypofractionated proton therapy for prostate cancer.

Provide website feedback?

Site Feedback